Page 338 - SAMRC Annual Report 2024-2025

NOTES TO THE ANNUAL FINANCIAL STATEMENTS

(CONTINUED)

49. Risk management (continued)

Cash flow interest rate risk
DUE IN DUE IN DUE IN DUE
DUE IN ONE TO TWO TO THREE TO AFTER
CURRENT LESS THAN TWO THREE FOUR FIVE
INTEREST A YEAR YEARS YEARS YEARS YEARS
FINANCIAL INSTRUMENT RATE R R R R R
Trade and other receivables –
normal credit terms 11.00% 95,886,370 – – – –
Cash in current banking
institutions – % 679,806,132 – – – –
Trade and other payables –
extended credit terms 11.00% 103,019,401 – – – –

Foreign exchange risk
The entity does not hedge foreign exchange fluctuations.
Exchange rates on 31 March 2025 (31 March 2024) used for conversion of foreign items were:
2025 2024
31 MARCH 31 MARCH
R R
USD – ABSA buying 18.3032 18.9214
USD – ABSA selling 18.3203 18.9364
GBP – ABSA buying 23.6441 23.8123
GBP – ABSA selling 23.6680 23.8388
EURO – ABSA buying 17.7986 –
EURO – ABSA selling 19.8189 20.3798
CHF – ABSA buying .0483 –
NAIRA – ABSA selling – 70.8833
KES – ABSA selling 7.0523 –
ZMW – ABSA selling 1.5309 –
The entity reviews its foreign currency exposure, including commitments on an ongoing basis. The entity has CFC
accounts for specific foreign income grants whose payments are mainly made in foreign currency. The risk for
currency fluctuations is eliminated by maintaining the CFC accounts for these grants.

The SAMRC has been affected by the recent research funding cuts from United States of America. SAMRC is
actively engaging with government to address the crisis and is currently reviewing alternative funding options.

336 SAMRC ANNUAL REPOR T 2025-26